EVQLV develops artificial intelligence, engineered with life science data, to accelerate how biologic therapies reach patients. They work with partners at the discovery stage to accelerate the speed of antibody discovery.

Biotechnology

EVQLV

EVQLV's headquarters in New York, NY, United States

Andrew Satz

Richard Fox

Ben Maida

Alexander Sonneborn

Brett Averso

Roland Dunbrack

Simeon Simeonov

Boris Shor

Ken Moch

Ron Lennox

Vikas Goyal

Victor Greiff

The Advisory Team at EVQLV consists of seasoned experts who provide strategic guidance and insights to optimize the use of artificial intelligence in accelerating antibody discovery. They collaborate with partners to identify opportunities, mitigate risks, and enhance the efficacy and speed of biologic therapy development.

Advisory Team

The Leadership Team at EVQLV comprises key executives responsible for setting strategic direction and driving the company's mission to enhance biologic therapy delivery through AI. With a focus on fostering partnerships and innovation, the team collaborates to guide operational initiatives, manage stakeholder relationships, and ensure alignment between scientific advancements and commercial viability. Their collective expertise shapes the future of antibody discovery and accelerates the journey from research to patient care.

Leadership Team

EVQLV

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

EVQLV

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies